Patents by Inventor Christopher John WEIR

Christopher John WEIR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
    Publication number: 20190358291
    Abstract: The present invention relates to the treatment and prevention of cancer. The present invention relates to vaccines comprising solubilized components of cancer cells or cancer-associated cells. Moreover, the present invention also relates to methods of producing vaccines from biological samples comprising cancer cells or cancer-associated cells and using said vaccines for the treatment or prevention of cancer in subjects. The present invention also relates to methods of producing vaccines, in particular, autologous vaccines. The present invention also relates to therapeutic uses of mesenchymal stem cells and to methods of treatment and or prevention that comprise administering mesenchymal stem cells to a subject. The present invention also relates to methods of enhancing the efficacy of vaccines and methods for the treatment and prevention of cancer, and to compositions and kits suitable for use in the methods.
    Type: Application
    Filed: June 12, 2019
    Publication date: November 28, 2019
    Inventors: Ross Arthur DAVEY, Christopher John WEIR, Graham VESEY
  • Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
    Patent number: 10357538
    Abstract: The present invention relates to the treatment and prevention of cancer. The present invention relates to vaccines comprising solubilized components of cancer cells or cancer-associated cells. Moreover, the present invention also relates to methods of producing vaccines from biological samples comprising cancer cells or cancer-associated cells and using said vaccines for the treatment or prevention of cancer in subjects. The present invention also relates to methods of producing vaccines, in particular, autologous vaccines. The present invention also relates to therapeutic uses of mesenchymal stem cells and to methods of treatment and or prevention that comprise administering mesenchymal stem cells to a subject. The present invention also relates to methods of enhancing the efficacy of vaccines and methods for the treatment and prevention of cancer, and to compositions and kits suitable for use in the methods.
    Type: Grant
    Filed: December 24, 2013
    Date of Patent: July 23, 2019
    Assignee: NORTHERN SYDNEY LOCAL HEALTH DISTRICT
    Inventors: Ross Arthur Davey, Christopher John Weir
  • Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
    Publication number: 20150343040
    Abstract: The present invention relates to the treatment and prevention of cancer. The present invention relates to vaccines comprising solubilized components of cancer cells or cancer-associated cells. Moreover, the present invention also relates to methods of producing vaccines from biological samples comprising cancer cells or cancer-associated cells and using said vaccines for the treatment or prevention of cancer in subjects. The present invention also relates to methods of producing vaccines, in particular, autologous vaccines. The present invention also relates to therapeutic uses of mesenchymal stem cells and to methods of treatment and or prevention that comprise administering mesenchymal stem cells to a subject. The present invention also relates to methods of enhancing the efficacy of vaccines and methods for the treatment and prevention of cancer, and to compositions and kits suitable for use in the methods.
    Type: Application
    Filed: December 24, 2013
    Publication date: December 3, 2015
    Inventors: Ross Arthur DAVEY, Christopher John WEIR, Graham VESEY